GlassScriptPhysician profile
Dylan T Mooney
NPI 1710335641
$1,747.14
in general payments reported to CMS, 2019-2025
16 companies · $294 in 2025
The $294 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $167 · 2021: $438 · 2022: $152 · 2023: $269 · 2024: $105 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $667.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $298.05 | 2021-2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $264.76 | 2019-2021 | |
| Abbvie INC. | $233.21 | 2019-2023 | |
| Neurocrine Biosciences, INC. | $184.74 | 2019-2021 | |
| Lilly USA, LLC | $163.14 | 2020-2024 | Zepbound |
| Hologic Sales and Service, LLC | $150.10 | 2025 | Aptima, Thinprep 2000 Processor |
| Pulmonx Corporation | $131.22 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Zephyr Delivery Catheter |
| Amgen INC. | $128.73 | 2023 | Repatha |
| Astellas Pharma US INC | $62.80 | 2020-2021 | |
| Dynavax Technologies Corporation | $27.35 | 2022-2025 | Heplisav-B |
| Biohaven Pharmaceuticals, INC. | $24.61 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $18.55 | 2021 | |
| Novo Nordisk INC | $17.63 | 2022 | |
| Allergan, INC. | $16.23 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $13.51 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.51 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dylan Mooney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.